Journal Home
Search for

Volume 39, Issue 2, Pages 241-249 (February 2010)


View previous. 14 of 249 View next.

A Single Set of Numerical Cutpoints to Define Moderate and Severe Symptoms for the Edmonton Symptom Assessment System

Debbie Selby, MD, FRCPCaCorresponding Author Informationemail address, Alisa Cascella, BSc (C)a, Kate Gardiner, BSca, Randy Do, BSc (C)a, Veronika Moravan, MScc, Jeff Myers, MD, CCFPa, Edward Chow, MBBS, PhD, FRCPCb

Accepted 13 July 2009. published online 07 December 2009.

Abstract 

Symptom intensity in cancer and palliative care patients is frequently assessed using a 0–10 ranking score. Results are then often grouped into verbal categories (mild, moderate, or severe) to guide therapy. Numerical cutpoints separating these categories are often variable, with previous work suggesting different cutpoints across different symptoms, which is unwieldy for clinical use. The Edmonton Symptom Assessment Symptom (ESAS) assesses nine common symptoms using this 0–10 scale. The primary aim of this study was to examine the relationship between the numerical and verbal scores using the ESAS and to identify a single cutpoint to separate severe from nonsevere symptomatology. A second goal was to similarly identify a cutpoint to separate moderate or severe from none or mild symptom intensity. Consenting patients (n=400) completed both a standard ESAS and an identical form that replaced 0–10 with none, mild, moderate, and severe. Receiver operating characteristic curves were generated to identify the best fit between sensitivity and specificity. For the “severe” ranking, six symptoms had a best fit of 7, with sensitivity for the remaining three symptoms still greater than 80%. For the combined grouping of moderate or severe, results were less uniform. A cutpoint of either 4 or 5 would be supported by our data, with a greater sensitivity using 4 and improved specificity using 5 as the cutpoint. Across all ESAS symptoms, then, 7 or higher represents a severe symptom by patient definition, whereas a cutpoint of either 4 or 5 could reasonably define combined moderate and severe symptoms.

a Palliative Care Department, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

b Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

c Private Practice, Toronto, Ontario, Canada

Corresponding Author InformationAddress correspondence to: Debbie Selby, MD, FRCPC, Palliative Care Department, Sunnybrook Health Sciences Center, University of Toronto, 2075 Bayview Avenue, H336, Toronto, Ontario M4N 3M5, Canada.

PII: S0885-3924(09)00843-4

doi:10.1016/j.jpainsymman.2009.06.010


View previous. 14 of 249 View next.